Related Experiment Video
Updated: May 18, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Parkinson's disease subtypes: lost in translation?
1Toronto Western Hospital, Movement Disorders Centre, 399 Bathurst St 7 MCL, Toronto, ON M5T 2S8, Canada. cmarras@uhnres.utoronto.ca
Journal of Neurology, Neurosurgery, and Psychiatry
|September 7, 2012
Summary
Parkinson's disease (PD) subtypes, identified by distinct clinical features, offer insights into disease causes and progression. However, these subtypes are underutilized in research, necessitating better integration for improved understanding and treatment strategies.
Area of Science:
- Neuroscience
- Neurology
- Clinical Research
Background:
- Parkinson's disease (PD) exhibits significant clinical heterogeneity, suggesting underlying biological variations.
- Previous studies have identified distinct PD subtypes based on clustering clinical features.
Purpose of the Study:
- To review identified Parkinson's disease subtypes and their validation.
- To discuss the implications of PD subtypes for understanding disease aetiology, progression, and treatment responsiveness.
- To recommend strategies for better integration of PD subtypes into clinical research and practice.
Main Methods:
- Literature review of identified Parkinson's disease subtypes.
- Analysis of subtype validation studies.
- Discussion of subtype incorporation into etiological, progression, and treatment research.
Main Results:
- Various Parkinson's disease subtypes have been proposed and validated to varying degrees.
- Clinical heterogeneity in PD likely reflects distinct pathophysiological differences.
- Subtypes are currently underutilized in PD clinical research and knowledge translation.
Conclusions:
- Parkinson's disease subtypes represent a valuable tool for dissecting disease mechanisms and improving research.
- Enhanced integration of PD subtypes is crucial for advancing etiological studies, predicting disease course, and optimizing treatment strategies.
- Practical recommendations are needed to bridge the gap between subtype identification and clinical application in Parkinson's disease research.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...